Scandinavian Real Heart AB (Publ) (HEART.ST) Research

Scandinavian Real Heart AB (Publ), a Swedish enterprise established in 2007, specializes in the innovation and production of artificial heart devices. The company's core focus is the Realheart TAH, a total artificial heart engineered specifically to address severe cases of heart failure. Beyond this central project, their product portfolio also encompasses medical solutions such as the RealVAD, PulsePump, and Sternal Prosthesis. The firm operates from its base in Västerås, Sweden.

Market snapshot

Symbol
HEART.ST
Price
$23.20
Day change
+1.75%
Market cap
$114.6M
P/E ratio
-2.01x
52-week range
12.85-30
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Alligator Bioscience AB (publ) (ATORX.ST)
  • Iconovo AB (publ) (ICO.ST)
  • Kontigo Care AB (publ) (KONT.ST)
  • Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
  • Luxbright AB (publ) (LXB.ST)
  • ScandiDos AB (publ) (SDOS.ST)
  • Simris Alg AB (publ) (SIMRIS-B.ST)
  • Spago Nanomedical AB (publ) (SPAGO.ST)

Open Scandinavian Real Heart AB (Publ) (HEART.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.